Literature DB >> 2289087

Integrated phylogeny of the primate brain, with special reference to humans and their diseases.

S I Rapoport1.   

Abstract

Fossil, comparative anatomic and ontogenic data suggest that several systems of functionally and anatomically related brain regions underwent selective expansion or differentiation during primate evolution, according to the principle of 'integrated phylogeny'. This process was closely tied to expansion of the neocortex, particularly of its association areas. System I regions include the association neocortices as well as the nucleus basalis of Meynert, the entorhinal cortex, and subdivisions of the septum, hippocampal formation and amygdaloid complex. This system undergoes degeneration in Alzheimer's and Pick's diseases and Down syndrome. System II includes segregated circuits involving parts of the frontal cortex, basal ganglia, thalamus, and substantia nigra, and can become defective in obsessive-compulsive disorder, Huntington's and Parkinson's diseases. Certain nuclei in the mesencephalon and brainstem, which co-evolved with System I and II regions, also demonstrate pathology in diseases affecting these systems. Integrated phylogeny of each of these systems during primate evolution likely was promoted by regulatory mutations, gene duplications or chromosomal rearrangements. Thus, understanding the genetic basis of integrated phylogeny of systems of brain regions during primate evolution may elucidate the pathogenesis of the human diseases which affect these regions.

Entities:  

Mesh:

Year:  1990        PMID: 2289087     DOI: 10.1016/0165-0173(90)90004-8

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  18 in total

1.  A neuronal morphologic type unique to humans and great apes.

Authors:  E A Nimchinsky; E Gilissen; J M Allman; D P Perl; J M Erwin; P R Hof
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Synaptosomal lactate dehydrogenase isoenzyme composition is shifted toward aerobic forms in primate brain evolution.

Authors:  Tetyana Duka; Sarah M Anderson; Zachary Collins; Mary Ann Raghanti; John J Ely; Patrick R Hof; Derek E Wildman; Morris Goodman; Lawrence I Grossman; Chet C Sherwood
Journal:  Brain Behav Evol       Date:  2014-03-28       Impact factor: 1.808

Review 3.  Accumulation of nuclear DNA damage or neuron loss: molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases.

Authors:  Ivona Brasnjevic; Patrick R Hof; Harry W M Steinbusch; Christoph Schmitz
Journal:  DNA Repair (Amst)       Date:  2008-05-23

4.  Postnatal development of the human primary motor cortex: a quantitative cytoarchitectonic analysis.

Authors:  K Amunts; V Istomin; A Schleicher; K Zilles
Journal:  Anat Embryol (Berl)       Date:  1995-12

5.  Biomarkers and evolution in Alzheimer disease.

Authors:  Stanley I Rapoport; Peter T Nelson
Journal:  Prog Neurobiol       Date:  2011-07-23       Impact factor: 11.685

Review 6.  Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-11-01       Impact factor: 10.005

Review 7.  Neurotrophins and the primate central nervous system: a minireview.

Authors:  M Hayashi
Journal:  Neurochem Res       Date:  1996-07       Impact factor: 3.996

8.  Studying microRNAs in the brain: technical lessons learned from the first ten years.

Authors:  Sébastien S Hébert; Peter T Nelson
Journal:  Exp Neurol       Date:  2011-12-08       Impact factor: 5.330

9.  Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease.

Authors:  M B Schapiro; P Pietrini; C L Grady; M J Ball; C DeCarli; A Kumar; J A Kaye; J V Haxby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

10.  Multisensory integration in early vestibular processing in mice: the encoding of passive vs. active motion.

Authors:  Ioana Medrea; Kathleen E Cullen
Journal:  J Neurophysiol       Date:  2013-10-02       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.